The role of mesenchymal stromal cells (MSCs) in regulating immune responses in the thymus is currently unclear. Here we report the existence and role of a MSC population in the thymus that expresses the pericyte and MSC marker CD248 (endosialin). We show using a CD248-deficient mouse model, that CD248 expression on these cells is required for full post-natal thymus development and regeneration post-Salmonella infection. In CD248(-/-) mice the thymus is hypocellular and regeneration is poorer, with significant loss of all thymocyte populations. This identifies the requirement of CD248 to maintain optimal thymic cellularity post-partum and infection.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642154 | PMC |
| http://dx.doi.org/10.1016/j.fob.2012.07.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CD248 Cleaved Form in Human Colorectal Cancer Stroma: Implications for Tumor Behavior and Prognosis.
Lab Invest
November 2024
Unité de Recherche en Pharmaco-Immunologie (UR-EPI), Université et CHU de La Réunion, Saint-Denis, France; Service d'Anatomie et Cytologie Pathologiques, CHU de La Réunion site SUD-Saint-Pierre, Saint-Pierre Cedex, France; Tumorothèque régionale de La Réunion, CHU de La Réunion site SUD-Saint-Pierre, Saint-Pierre Cedex, France. Electronic address:
CD248 (endosialin/tumor endothelial marker 1) is upregulated in cancer, including colorectal cancer (CRC), but its exact role in tumor progression remains to be elucidated. Previous studies have shown that the extracellular domain of CD248 mediates the interaction between tumor cells and extracellular matrix proteins and that interfering with this interaction may reduce tumor invasion and migration activities. We have examined the expression of CD248 in 117 human CRC samples by immunohistochemistry and investigated the association with various clinicopathologic features, including the occurrence of metastasis, intratumoral immune cell density and overall survival.
View Article and Find Full Text PDFFunctional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma.
Biomark Res
September 2024
Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University, NO. 569 Xinsi Road, Xi'an, 710038, China.
Article Synopsis
- A novel combination of neoadjuvant immunotherapy and chemotherapy (neoICT) has shown promise in improving outcomes for esophageal squamous-cell carcinoma (ESCC) patients, but issues like low response rates and therapy resistance remain.
- *Using advanced techniques like single-cell RNA sequencing and multiplexed immunofluorescence, the study examined the tumor microenvironment (TME) to understand why some patients respond better to treatment than others.
- *The research highlighted specific cancer-associated fibroblast (CAF) populations, particularly IL6+ CCL2+ and CD248+ CAFs, that contribute to therapy resistance by blocking T cell infiltration and inducing unfavorable immune responses, suggesting new targets for improving treatment effectiveness.
Deciphering the Dysregulating IGF-1-SP1-CD248 Pathway in Fibroblast Functionality during Diabetic Wound Healing.
J Invest Dermatol
September 2024
Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Electronic address:
Reduced fibroblast activity is a critical factor in the progression of diabetic ulcers. CD248, a transmembrane glycoprotein prominently expressed in activated fibroblasts, plays a pivotal role in wound healing. However, the role of CD248 in diabetic wound healing and the CD248 regulatory pathway remains largely unexplored.
View Article and Find Full Text PDFEndosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8 T cell infiltration.
J Immunother Cancer
September 2024
Xi'an Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Research, Northwestern Polytechnical University, Xi'an, China
Background And Aims: Endosialin, also known as tumor endothelial marker1 or CD248, is a transmembrane glycoprotein that is mainly expressed in cancer-associated fibroblasts (CAFs) in hepatocellular carcinoma (HCC). Our previous study has found that endosialin-positive CAFs could recruit and induce the M2 polarization of macrophages in HCC. However, whether they may regulate other types of immune cells to promoting HCC progression is not known.
View Article and Find Full Text PDFImmunophenotypical Characterization of Limbal Mesenchymal Stromal Cell Subsets during In Vitro Expansion.
Int J Mol Sci
August 2024
Regenerative Medicine, Department of Health Science and Technology, Aalborg University, 9260 Gistrup, Denmark.
Limbal mesenchymal stromal cells (LMSCs) reside in the limbal niche, supporting corneal integrity and facilitating regeneration. While mesenchymal stem/stromal cells (MSCs) are used in regenerative therapies, there is limited knowledge about LMSC subpopulations and their characteristics. This study characterized human LMSC subpopulations through the flow cytometric assessment of fifteen cell surface markers, including MSC, wound healing, immune regulation, ASC, endothelial, and differentiation markers.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!